Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-18

Clinical Trial Update: Bioequivalence Study for an Isotretinoin [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study of isotretinoin for acne has completed, with the trial status shown as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ISOTRETINOIN (Isotretinoin)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Skin Infections (Acne) | Phase 1 | Status: COMPLETED